4//SEC Filing
XRpro Sciences, Inc. 4
Accession 0001213900-15-000634
CIK 0001518520operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 12:53 PM ET
Size
6.6 KB
Accession
0001213900-15-000634
Insider Transaction Report
Form 4
Cunningham, Richard Anthony
President and CEO
Transactions
- Award
Stock options
2015-01-07+500,000→ 500,000 totalExercise: $1.75From: 2015-11-24Exp: 2025-01-06→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]Pursuant to the terms of Mr. Cunningham's employment agreement (the "Employment Agreement") with XRpro Sciences Inc. (f/k/a Caldera Pharmaceuticals, Inc.) (the "Company"), Mr. Cunningham was awarded options exercisable for 500,000 shares of the Company's common stock on the closing date of the Company's first financing subsequent to Mr. Cunningham becoming the Company's President and Chief Executive Officer.
- [F2]The options vest as follows: (i) 100,000 options vest on November 24, 2015; (ii) 300,000 options vest monthly on a pro rata basis commencing on the last day of months thirteen (13) through forty eight (48) of the term of the Employment Agreement, which ends on November 24, 2018, unless terminated earlier; and (iii) 100,000 options vest on November 24, 2018.
Documents
Issuer
XRpro Sciences, Inc.
CIK 0001518520
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001518520
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 12:53 PM ET
- Size
- 6.6 KB